{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:42:24Z","timestamp":1762504944176},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.diagmicrobio.2004.04.015","type":"journal-article","created":{"date-parts":[[2004,8,17]],"date-time":"2004-08-17T13:09:01Z","timestamp":1092748141000},"page":"283-287","source":"Crossref","is-referenced-by-count":10,"title":["Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: A sample of North American isolates"],"prefix":"10.1016","volume":"49","author":[{"given":"Helio S","family":"Sader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M","family":"Streit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB1","doi-asserted-by":"crossref","first-page":"S159","DOI":"10.1097\/00006454-200012001-00005","article-title":"Comparative safety and efficacy of cefdinir vs. amoxicillin\/clavulanate for the treatment of suppurative acute otitis media in children","volume":"19","author":"Block","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0732-8893(94)90131-7","article-title":"In vitro evaluation of cefdinir (FK482), a new oral cephalosporin with enhanced antistaphylococcal activity and \u03b2-lactamase stability","volume":"18","author":"Cohen","year":"1994","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00003495-199244050-00011","article-title":"Cefpodoxime proxetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential","volume":"44","author":"Frampton","year":"1992","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB4","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2165\/00003495-200363140-00003","article-title":"A practical guide to the treatment of complicated skin and soft tissue infections","volume":"63","author":"Fung","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/jac\/dkf046","article-title":"Patient compliance with antibiotic treatment for respiratory tract infections","volume":"49","author":"Kardas","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB6","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1097\/00006454-200003000-00001","article-title":"Summary","volume":"19","author":"Klein","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 1","key":"10.1016\/j.diagmicrobio.2004.04.015_BIB7","first-page":"1","article-title":"Acute otitis media in pediatric medicine","volume":"5","author":"Leibovitz","year":"2003","journal-title":"Paediatr Drug"},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2004.04.015_BIB8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1469-0691.2000.tb02047.x","article-title":"The new oral cephalosporins in community-acquired infections","volume":"6","author":"Low","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB9","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.7164\/antibiotics.41.1873","article-title":"In vitro antibacterial activity of FK482, a new orally active cephalosporin","volume":"41","author":"Mine","year":"1988","journal-title":"J Antibiot"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB10","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS) (2003). Methods for dilution antimicrobial tests for bacteria that grows aerobically. Approved standard M7-A6. Wayne, PA:NCCLS"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB11","unstructured":"National Committee for Clinical Laboratory Standards (NCCLS) (2004). Performance standards for antimicrobial susceptibility testing. Supplemental tables, M100-S14. Wayne, PA:NCCLS"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB12","unstructured":"Package insert (2001). Omnicef (cefdinir), Abbott Laboratories, North Chicago IL. Available at http:\/\/www.rxabbott.com\/pdf\/omnicef.PDF. [Accessed on April 17, 2004.]"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB13","doi-asserted-by":"crossref","first-page":"S174","DOI":"10.1097\/00006454-200012001-00008","article-title":"Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin\/clavulanate potassium, cefprozil and azithromycin in pediatric patients","volume":"19","author":"Powers","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB14","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00006454-200012001-00002","article-title":"Pharmacodynamics and pharmacokinetics of cefdinir, an oral extended spectrum cephalosporin","volume":"19","author":"Guay","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.diagmicrobio.2004.04.015_BIB15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0732-8893(03)00165-2","article-title":"Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared to other orally administered antimicrobials tested against common respiratory tract pathogens","volume":"47","author":"Sader","year":"2003","journal-title":"Diag Microbiol Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889304000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889304000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T21:53:47Z","timestamp":1549317227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889304000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0732889304000835"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2004.04.015","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}